Cargando…
Activation of TLR-pathway to induce host Th1 immune response against visceral leishmaniasis: Involvement of galactosylated-flavonoids
Immunotherapeutic strategies against visceral leishmaniasis (VL) are pertinent because of the emergence of resistance against existing chemotherapy, coupled with their toxicity and high costs. Various bioactive components with potential immunomodulatory activity, such as alkaloids, terpenes, saponin...
Autores principales: | Pradhan, Supratim, Snehlata, Manna, Debolina, Karmakar, Subir, Singh, Manoj Kumar, Bhattacharya, Arijit, Mukherjee, Budhaditya, Paul, Joydeep |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9284459/ https://www.ncbi.nlm.nih.gov/pubmed/35847617 http://dx.doi.org/10.1016/j.heliyon.2022.e09868 |
Ejemplares similares
-
TLR4 and NKT Cell Synergy in Immunotherapy against Visceral Leishmaniasis
por: Karmakar, Subir, et al.
Publicado: (2012) -
Short-Course Treatment With Imipramine Entrapped in Squalene Liposomes Results in Sterile Cure of Experimental Visceral Leishmaniasis Induced by Antimony Resistant Leishmania donovani With Increased Efficacy
por: Mukherjee, Sandip, et al.
Publicado: (2020) -
Synthesis and biological activity of α-galactosyl ceramide KRN7000 and galactosyl (α1→2) galactosyl ceramide
por: Veerapen, Natacha, et al.
Publicado: (2009) -
Visceral leishmaniasis
por: Sundar, Shyam
Publicado: (2015) -
TLR4 and TLR9 polymorphism: Probable role in susceptibility among the population of Bihar for Indian visceral leishmaniasis
por: Mandal, Abhishek, et al.
Publicado: (2021)